NRSN Stock Analysis: Buy, Sell, or Hold?
NRSN - NeuroSense Therapeutics Ltd. Ordinary Shares
$0.50
0.03 (6.84%)
▲
5d:
-15.33%
30d:
-29.8%
90d:
-44.57%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When NRSN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NRSN is down 15.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NRSN is down 15.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NRSN is currently trading at $0.50, which is considered oversold relative to its 30-day fair value range of $0.57 to $0.75.
Technical Outlook: Technically, NRSN is in a downtrend. Immediate support is located at $0.39, while resistance sits at $0.72. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.50 (+1297.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRSN is in a downtrend. Immediate support is located at $0.39, while resistance sits at $0.72. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.50 (+1297.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.57 -
$0.75
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 1297.2% below Wall St target ($6.50)
- WARNING: Recommendation downgraded due to -15.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.57 -
$0.75
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.39
Resistance Level
$0.72
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.57
Wall Street Target
$6.50
(+1297.2%)
Share & Embed Analysis
Last updated: August 03, 2026 3:12 PM ET
Data refreshes hourly during market hours. Next update: 4:12 PM
Data refreshes hourly during market hours. Next update: 4:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRSN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
